Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12515812 2024-04-01 2025-03-31 12515812 2023-04-01 2024-03-31 12515812 2025-03-31 12515812 2024-03-31 12515812 c:Director1 2024-04-01 2025-03-31 12515812 c:Director2 2024-04-01 2025-03-31 12515812 d:CurrentFinancialInstruments 2025-03-31 12515812 d:CurrentFinancialInstruments 2024-03-31 12515812 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 12515812 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 12515812 d:ShareCapital 2025-03-31 12515812 d:ShareCapital 2024-03-31 12515812 d:RetainedEarningsAccumulatedLosses 2025-03-31 12515812 d:RetainedEarningsAccumulatedLosses 2024-03-31 12515812 c:OrdinaryShareClass1 2024-04-01 2025-03-31 12515812 c:OrdinaryShareClass1 2025-03-31 12515812 c:OrdinaryShareClass1 2024-03-31 12515812 c:OrdinaryShareClass2 2024-04-01 2025-03-31 12515812 c:OrdinaryShareClass2 2025-03-31 12515812 c:OrdinaryShareClass2 2024-03-31 12515812 c:FRS102 2024-04-01 2025-03-31 12515812 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12515812 c:FullAccounts 2024-04-01 2025-03-31 12515812 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12515812 e:PoundSterling 2024-04-01 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 12515812









HEALTHWORKS ASSOCIATES LIMITED

UNAUDITED

FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
HEALTHWORKS ASSOCIATES LIMITED
REGISTERED NUMBER: 12515812

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
20,935
41,041

Cash at bank and in hand
  
60,762
50,188

  
81,697
91,229

Creditors: amounts falling due within one year
 5 
(31,048)
(42,215)

Net current assets
  
 
 
50,649
 
 
49,014

Total assets less current liabilities
  
50,649
49,014

  

Net assets
  
50,649
49,014


Capital and reserves
  

Called up share capital 
  
90
90

Profit and loss account
  
50,559
48,924

  
50,649
49,014


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 27 November 2025.




N A Wilson
R B Derrett
Director
Director

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
HEALTHWORKS ASSOCIATES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Healthworks Associates Limited is a private company, limited by shares, incorporated in England and Wales with the registration number 12515812. The address of the registered office is Anglia House, 6 Central Avenue, St Andrews Business Park, Thorpe St Andrew, Norwich, NR7 0HR. 

The financial statements are prepared in sterling which is the functional currency of the company and rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 2

 
HEALTHWORKS ASSOCIATES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 3

 
HEALTHWORKS ASSOCIATES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Debtors

2025
2024
£
£


Trade debtors
20,805
24,616

Prepayments and accrued income
130
16,425

20,935
41,041



5.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
610
276

Corporation tax
566
-

Other taxation and social security
20,510
21,523

Other creditors
2,127
1,503

Accruals and deferred income
7,235
18,913

31,048
42,215



6.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



45 (2024 - 45) A class shares of £1.00 each
45
45
45 (2024 - 45) B class shares of £1.00 each
45
45

90

90



7.


Related party transactions

At 1 April 2024 the directors were owed monies from the Company totalling £1,503. During the year the directors withdrew monies totalling £1,000 and introduced monies totalling £1,624 leaving a balance of £2,127 due from the Company at 31 March 2025. No interest was charged on this balance which is repayable on demand.


Page 4